Laverock Therapeutics expands team by 50% and adds a new FD
Laverock significantly grow the team by 50% in last year.
Laverock significantly grow the team by 50% in last year.
Riff Raff strikes TV development deal with Newen Connect with the first project to be a political thriller starring Riff Raff founder Jude Law.
Spectral Receives UKCA Authorization for Burn Indication Expected Commercialization 2nd Half 2024.
Optalitix partner with Quantee, in exciting partnership
Invizius announce the first two patients have been treated at the National Institute for Health and Care Research (NIHR) Manchester Clinical Research Facility (CRF) with lead product, H-Guard® Priming Solution.
The start of this trial investigating its lead asset OBT076 in Adenoid Cystic Carcinoma (ACC) is a major milestone for OBT.
Boy Swallows Universe has become a hit since landing on Netflix.